Top Markets
Coin of the day
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
주식 순위 #41146
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
주가
$0.04082105
마지막 동기화: 2024-08-12
시가총액
$39.09K
변동 (1일)
-19.83%
변동 (1년)
0.00%
국가
GB
거래 Destiny Pharma plc (DEST)

카테고리

Destiny Pharma plc (DEST)의 배당 수익률 기록
Destiny Pharma plc (주식 심볼: DEST)의 배당 수익률 (TTM)은 2022-12-31 기준으로 0.00%입니다.
지난 5년 평균 배당 수익률: 0.00%
Destiny Pharma plc (DEST)의 배당 수익률 기록: 2013 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
유사 기업 또는 경쟁사의 배당 수익률 (TTM)